PMID: 376044Apr 28, 1979Paper

Mammary cancers and pregnancy

British Medical Journal
J M Anderson

Abstract

Uncertainties persist about management and prognosis of mammary cancers that occur during and after pregnancy and during lactation. Pathological features of mammary cancers occurring during pregnancy are the same as those in non-pregnant women and survival rates are comparable. Management should be the same as in non-pregnant patients. Termination of pregnancy does not improve survival but it should be advised if the prognosis is poor. Mastectomy apparently presents little danger to the fetus, though treatment such as chemotherapy and irradiation should be avoided. Women who have received treatment for mammary cancer need not be advised against subsequent pregnancy. Routine ovarian radiation in non-pregnant premenopausal women is not generally to be recommended, since it does not prolong survival and would deprive some of the chance of further pregnancy. In lactating women who develop mammary cancers survival is apparently not adversely affected. Lactation should be suppressed initially and followed by mastectomy. Regimens of immunotherapy, chemotherapy, or radiotherapy may then be begun. Until results of current trials of combined treatments of mammary cancers associated with pregnancy are available, management should be neith...Continue Reading

References

Jan 31, 1976·Lancet·A F RojasA J Olivari
Dec 10, 1977·British Medical Journal·G G Ribeiro, M K Palmer
Jan 16, 1975·The New England Journal of Medicine·B FisherE R Fisher
Feb 19, 1976·The New England Journal of Medicine·G BonadonnaU Veronesi
Oct 14, 1972·Lancet·R W Miller, W J Blot
Oct 1, 1974·The British Journal of Surgery·J M AndersonK E Halnan
Aug 1, 1970·The British Journal of Surgery·J M AndersonG Hannah
Jul 16, 1964·The New England Journal of Medicine·P G RIGBYR S SMITH
Aug 1, 1965·Cancer·I BRODSKYM TELLEM

❮ Previous
Next ❯

Citations

Aug 18, 2010·Breast Cancer Research and Treatment·Ma Concepción Sánchez Martínez, Amparo Ruiz Simón
Jun 12, 2002·Current Treatment Options in Oncology·K M Gwyn, R L Theriault
Oct 1, 1995·American Journal of Surgery·C E Scott-Conner, S J Schorr
Nov 26, 1999·The Surgical Clinics of North America·M L GemignaniP I Borgen
May 12, 2001·The Breast Journal·Mary L. Gemignani, Jeanne A. Petrek
Jul 27, 2011·Therapeutic Advances in Medical Oncology·Sophie E McGrath, Alistair Ring
Jun 1, 2007·BMC Cancer·Michael J Naughton, Matthew Ellis
Sep 1, 2005·Women's Health·Richard L Theriault, Alyssa G Rieber
Apr 28, 2009·Women's Health·Jennifer K LittonAna M Gonzalez-Angulo
Feb 18, 2006·Radiology·Wei Tse YangRichard Theriault
Mar 1, 1992·American Journal of Obstetrics and Gynecology·D ZemlickisG Koren
Mar 16, 2013·Medicina clínica·Sonia BauliesRafael Fábregas
Jul 15, 2011·Clinical Breast Cancer·Steffi HartmannBernd Gerber
May 22, 2009·Gynécologie, obstétrique & fertilité·E VinatierD Vinatier
Apr 9, 2008·Critical Reviews in Oncology/hematology·Miriam S LenhardMichael Untch
Nov 29, 2005·Obstetrics and Gynecology Clinics of North America·Kimberly K Leslie, Carol A Lange
Sep 6, 2015·Diagnostic and Interventional Imaging·A LangerP Chérel
Apr 1, 1996·The Surgical Clinics of North America·L A DiFronzo, T X O'Connell
Mar 10, 2001·Cancer Treatment Reviews·E FenigM Lishner
Sep 1, 1996·Seminars in Surgical Oncology·D E Merkel
Aug 25, 2009·Obstetrics and Gynecology·Therese M-L AnderssonMats Lambe
Oct 16, 2004·Expert Review of Anticancer Therapy·Boaz WeiszMichael Lishner
Jan 1, 1984·Journal of Surgical Oncology·I M HoldawayR G Kay
Jul 1, 1994·Cancer·J A Petrek
Feb 1, 1996·Obstetrical & Gynecological Survey·N M AntonelliJ A Kuller
Jul 6, 2000·Acta Clinica Belgica·K SchotteS Van Belle
Sep 1, 1991·Seminars in Surgical Oncology·J A Petrek
Jan 1, 1981·Journal of Surgical Oncology·K SahniS Khanna
Feb 1, 1996·Obstetrical & Gynecological Survey·N M AntonelliJ A Kuller
Jun 23, 2005·The Cancer Journal·Amanda Psyrri, Barbara Burtness
May 20, 2003·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Bo Young AhnSeog Hee Park
Jul 1, 1980·Scottish Medical Journal·R Watson, J H Kennedy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.